nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP2C18—Tretinoin—peripheral nervous system neoplasm	0.203	0.343	CbGbCtD
Perphenazine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0641	0.108	CbGbCtD
Perphenazine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0485	0.0821	CbGbCtD
Perphenazine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0404	0.0684	CbGbCtD
Perphenazine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0339	0.0573	CbGbCtD
Perphenazine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0323	0.0547	CbGbCtD
Perphenazine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0274	0.0464	CbGbCtD
Perphenazine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0212	0.0358	CbGbCtD
Perphenazine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0204	0.0346	CbGbCtD
Perphenazine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0197	0.0333	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0184	0.0311	CbGbCtD
Perphenazine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0158	0.0267	CbGbCtD
Perphenazine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0145	0.0245	CbGbCtD
Perphenazine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00904	0.0153	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00888	0.015	CbGbCtD
Perphenazine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00828	0.014	CbGbCtD
Perphenazine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00826	0.0891	CbGeAlD
Perphenazine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00565	0.00956	CbGbCtD
Perphenazine—CALM1—trigeminal nerve—peripheral nervous system neoplasm	0.00496	0.0535	CbGeAlD
Perphenazine—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00453	0.0489	CbGeAlD
Perphenazine—HTR6—ganglion—peripheral nervous system neoplasm	0.00376	0.0405	CbGeAlD
Perphenazine—CALM1—cranial nerve—peripheral nervous system neoplasm	0.00353	0.0381	CbGeAlD
Perphenazine—CALM2—pons—peripheral nervous system neoplasm	0.00351	0.0378	CbGeAlD
Perphenazine—CALM1—pons—peripheral nervous system neoplasm	0.00349	0.0376	CbGeAlD
Perphenazine—HTR7—cranial nerve—peripheral nervous system neoplasm	0.00345	0.0372	CbGeAlD
Perphenazine—HTR7—pons—peripheral nervous system neoplasm	0.00341	0.0368	CbGeAlD
Perphenazine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00302	0.0326	CbGeAlD
Perphenazine—DRD1—nerve—peripheral nervous system neoplasm	0.00283	0.0305	CbGeAlD
Perphenazine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00282	0.0305	CbGeAlD
Perphenazine—DRD1—ganglion—peripheral nervous system neoplasm	0.00279	0.0301	CbGeAlD
Perphenazine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00217	0.0234	CbGeAlD
Perphenazine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00215	0.0232	CbGeAlD
Perphenazine—HTR2A—pons—peripheral nervous system neoplasm	0.00213	0.0229	CbGeAlD
Perphenazine—HTR1A—ganglion—peripheral nervous system neoplasm	0.00183	0.0197	CbGeAlD
Perphenazine—CALM2—nerve—peripheral nervous system neoplasm	0.00182	0.0196	CbGeAlD
Perphenazine—CALM1—nerve—peripheral nervous system neoplasm	0.00181	0.0195	CbGeAlD
Perphenazine—CALM2—ganglion—peripheral nervous system neoplasm	0.0018	0.0194	CbGeAlD
Perphenazine—CALM1—ganglion—peripheral nervous system neoplasm	0.00179	0.0193	CbGeAlD
Perphenazine—HTR7—nerve—peripheral nervous system neoplasm	0.00177	0.0191	CbGeAlD
Perphenazine—HTR7—ganglion—peripheral nervous system neoplasm	0.00175	0.0188	CbGeAlD
Perphenazine—DRD2—nerve—peripheral nervous system neoplasm	0.00167	0.018	CbGeAlD
Perphenazine—DRD2—ganglion—peripheral nervous system neoplasm	0.00165	0.0178	CbGeAlD
Perphenazine—AOX1—trigeminal ganglion—peripheral nervous system neoplasm	0.00125	0.0135	CbGeAlD
Perphenazine—DRD1—brainstem—peripheral nervous system neoplasm	0.00121	0.0131	CbGeAlD
Perphenazine—CALM3—trigeminal ganglion—peripheral nervous system neoplasm	0.00112	0.0121	CbGeAlD
Perphenazine—HTR2A—nerve—peripheral nervous system neoplasm	0.0011	0.0119	CbGeAlD
Perphenazine—HTR2A—ganglion—peripheral nervous system neoplasm	0.00109	0.0117	CbGeAlD
Perphenazine—CALM3—parotid gland—peripheral nervous system neoplasm	0.00106	0.0114	CbGeAlD
Perphenazine—HTR2C—brainstem—peripheral nervous system neoplasm	0.000944	0.0102	CbGeAlD
Perphenazine—CALM2—trigeminal ganglion—peripheral nervous system neoplasm	0.000882	0.00952	CbGeAlD
Perphenazine—CALM1—trigeminal ganglion—peripheral nervous system neoplasm	0.000878	0.00947	CbGeAlD
Perphenazine—CALM2—parotid gland—peripheral nervous system neoplasm	0.000832	0.00898	CbGeAlD
Perphenazine—HTR1A—brainstem—peripheral nervous system neoplasm	0.000794	0.00857	CbGeAlD
Perphenazine—CALM2—brainstem—peripheral nervous system neoplasm	0.000781	0.00842	CbGeAlD
Perphenazine—CALM1—brainstem—peripheral nervous system neoplasm	0.000777	0.00838	CbGeAlD
Perphenazine—HTR7—brainstem—peripheral nervous system neoplasm	0.000759	0.00819	CbGeAlD
Perphenazine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.000722	0.169	CrCbGaD
Perphenazine—DRD2—brainstem—peripheral nervous system neoplasm	0.000718	0.00774	CbGeAlD
Perphenazine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.00064	0.00691	CbGeAlD
Perphenazine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000629	0.00679	CbGeAlD
Perphenazine—Triflupromazine—BCHE—peripheral nervous system neoplasm	0.000591	0.139	CrCbGaD
Perphenazine—AOX1—cerebellum—peripheral nervous system neoplasm	0.000544	0.00587	CbGeAlD
Perphenazine—CALM3—cerebellum—peripheral nervous system neoplasm	0.00049	0.00529	CbGeAlD
Perphenazine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000473	0.00511	CbGeAlD
Perphenazine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000431	0.00465	CbGeAlD
Perphenazine—Flupentixol—ABCB1—peripheral nervous system neoplasm	0.000425	0.0999	CrCbGaD
Perphenazine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000392	0.00422	CbGeAlD
Perphenazine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000386	0.00199	CcSEcCtD
Perphenazine—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000386	0.00199	CcSEcCtD
Perphenazine—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.000385	0.00199	CcSEcCtD
Perphenazine—CALM2—cerebellum—peripheral nervous system neoplasm	0.000385	0.00415	CbGeAlD
Perphenazine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000383	0.00198	CcSEcCtD
Perphenazine—CALM1—cerebellum—peripheral nervous system neoplasm	0.000383	0.00413	CbGeAlD
Perphenazine—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000382	0.00197	CcSEcCtD
Perphenazine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00038	0.00196	CcSEcCtD
Perphenazine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00038	0.00196	CcSEcCtD
Perphenazine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000379	0.00196	CcSEcCtD
Perphenazine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000379	0.00196	CcSEcCtD
Perphenazine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000375	0.00194	CcSEcCtD
Perphenazine—HTR7—cerebellum—peripheral nervous system neoplasm	0.000374	0.00404	CbGeAlD
Perphenazine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000374	0.00193	CcSEcCtD
Perphenazine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000373	0.00193	CcSEcCtD
Perphenazine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000371	0.00191	CcSEcCtD
Perphenazine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000371	0.00191	CcSEcCtD
Perphenazine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000369	0.00191	CcSEcCtD
Perphenazine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000368	0.0019	CcSEcCtD
Perphenazine—Pain—Topotecan—peripheral nervous system neoplasm	0.000368	0.0019	CcSEcCtD
Perphenazine—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.00189	CcSEcCtD
Perphenazine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000366	0.00189	CcSEcCtD
Perphenazine—Pain—Tretinoin—peripheral nervous system neoplasm	0.000365	0.00188	CcSEcCtD
Perphenazine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000365	0.00188	CcSEcCtD
Perphenazine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000365	0.00188	CcSEcCtD
Perphenazine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000365	0.00188	CcSEcCtD
Perphenazine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000364	0.00188	CcSEcCtD
Perphenazine—Abnormal dreams—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.00187	CcSEcCtD
Perphenazine—Dermatitis contact—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.00187	CcSEcCtD
Perphenazine—Pain—Melphalan—peripheral nervous system neoplasm	0.00036	0.00186	CcSEcCtD
Perphenazine—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.00184	CcSEcCtD
Perphenazine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.000355	0.00183	CcSEcCtD
Perphenazine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000354	0.00382	CbGeAlD
Perphenazine—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.000353	0.00182	CcSEcCtD
Perphenazine—Agitation—Vincristine—peripheral nervous system neoplasm	0.000351	0.00181	CcSEcCtD
Perphenazine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000348	0.0018	CcSEcCtD
Perphenazine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000346	0.00179	CcSEcCtD
Perphenazine—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000346	0.00178	CcSEcCtD
Perphenazine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000343	0.00177	CcSEcCtD
Perphenazine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.00176	CcSEcCtD
Perphenazine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000342	0.00176	CcSEcCtD
Perphenazine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000342	0.00176	CcSEcCtD
Perphenazine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00034	0.00175	CcSEcCtD
Perphenazine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000339	0.00175	CcSEcCtD
Perphenazine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000339	0.00175	CcSEcCtD
Perphenazine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000337	0.00174	CcSEcCtD
Perphenazine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000337	0.00174	CcSEcCtD
Perphenazine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000337	0.00174	CcSEcCtD
Perphenazine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000334	0.00173	CcSEcCtD
Perphenazine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000332	0.00172	CcSEcCtD
Perphenazine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000331	0.00171	CcSEcCtD
Perphenazine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00033	0.0017	CcSEcCtD
Perphenazine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000329	0.0017	CcSEcCtD
Perphenazine—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.000328	0.00169	CcSEcCtD
Perphenazine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.00168	CcSEcCtD
Perphenazine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000324	0.00167	CcSEcCtD
Perphenazine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.00167	CcSEcCtD
Perphenazine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000321	0.00166	CcSEcCtD
Perphenazine—Eczema—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00165	CcSEcCtD
Perphenazine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000318	0.00164	CcSEcCtD
Perphenazine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000318	0.00164	CcSEcCtD
Perphenazine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000317	0.00163	CcSEcCtD
Perphenazine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.00163	CcSEcCtD
Perphenazine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000314	0.00162	CcSEcCtD
Perphenazine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000314	0.00162	CcSEcCtD
Perphenazine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000311	0.00161	CcSEcCtD
Perphenazine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00031	0.0016	CcSEcCtD
Perphenazine—Infection—Vincristine—peripheral nervous system neoplasm	0.000309	0.0016	CcSEcCtD
Perphenazine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.00159	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00157	CcSEcCtD
Perphenazine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000304	0.00157	CcSEcCtD
Perphenazine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.00157	CcSEcCtD
Perphenazine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000303	0.00156	CcSEcCtD
Perphenazine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000302	0.00156	CcSEcCtD
Perphenazine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000302	0.00156	CcSEcCtD
Perphenazine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000302	0.00156	CcSEcCtD
Perphenazine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000302	0.00156	CcSEcCtD
Perphenazine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000298	0.00154	CcSEcCtD
Perphenazine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000298	0.00154	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000297	0.00153	CcSEcCtD
Perphenazine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000297	0.00153	CcSEcCtD
Perphenazine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000297	0.00153	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.00153	CcSEcCtD
Perphenazine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000295	0.00152	CcSEcCtD
Perphenazine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000294	0.00152	CcSEcCtD
Perphenazine—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000294	0.00152	CcSEcCtD
Perphenazine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000292	0.00151	CcSEcCtD
Perphenazine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00151	CcSEcCtD
Perphenazine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000292	0.00151	CcSEcCtD
Perphenazine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000292	0.00151	CcSEcCtD
Perphenazine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000291	0.0015	CcSEcCtD
Perphenazine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000288	0.00149	CcSEcCtD
Perphenazine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000288	0.00149	CcSEcCtD
Perphenazine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000287	0.00148	CcSEcCtD
Perphenazine—Domperidone—ABCB1—peripheral nervous system neoplasm	0.000286	0.0672	CrCbGaD
Perphenazine—Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.000285	0.0669	CrCbGaD
Perphenazine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000284	0.00147	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.00146	CcSEcCtD
Perphenazine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000282	0.00146	CcSEcCtD
Perphenazine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000282	0.00146	CcSEcCtD
Perphenazine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000282	0.00145	CcSEcCtD
Perphenazine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000281	0.00145	CcSEcCtD
Perphenazine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000277	0.00143	CcSEcCtD
Perphenazine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.00143	CcSEcCtD
Perphenazine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.00143	CcSEcCtD
Perphenazine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000276	0.00142	CcSEcCtD
Perphenazine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000275	0.00142	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.00142	CcSEcCtD
Perphenazine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000274	0.00296	CbGeAlD
Perphenazine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000274	0.00141	CcSEcCtD
Perphenazine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000274	0.00141	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.00141	CcSEcCtD
Perphenazine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000272	0.0014	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.0014	CcSEcCtD
Perphenazine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000271	0.0014	CcSEcCtD
Perphenazine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000271	0.0014	CcSEcCtD
Perphenazine—Cough—Etoposide—peripheral nervous system neoplasm	0.00027	0.00139	CcSEcCtD
Perphenazine—Headache—Topotecan—peripheral nervous system neoplasm	0.000269	0.00139	CcSEcCtD
Perphenazine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000269	0.00139	CcSEcCtD
Perphenazine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000268	0.00138	CcSEcCtD
Perphenazine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000267	0.00138	CcSEcCtD
Perphenazine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000267	0.00138	CcSEcCtD
Perphenazine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000267	0.00138	CcSEcCtD
Perphenazine—Pain—Vincristine—peripheral nervous system neoplasm	0.000266	0.00137	CcSEcCtD
Perphenazine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000266	0.00137	CcSEcCtD
Perphenazine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000263	0.00136	CcSEcCtD
Perphenazine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000262	0.00135	CcSEcCtD
Perphenazine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000257	0.00133	CcSEcCtD
Perphenazine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000257	0.00133	CcSEcCtD
Perphenazine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000257	0.00133	CcSEcCtD
Perphenazine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000255	0.00132	CcSEcCtD
Perphenazine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000254	0.00131	CcSEcCtD
Perphenazine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00131	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.00131	CcSEcCtD
Perphenazine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000252	0.0013	CcSEcCtD
Perphenazine—Infection—Etoposide—peripheral nervous system neoplasm	0.000251	0.00129	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.00129	CcSEcCtD
Perphenazine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000249	0.00128	CcSEcCtD
Perphenazine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000249	0.00128	CcSEcCtD
Perphenazine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000246	0.00127	CcSEcCtD
Perphenazine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000246	0.00127	CcSEcCtD
Perphenazine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000246	0.00127	CcSEcCtD
Perphenazine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000246	0.00127	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.00126	CcSEcCtD
Perphenazine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00024	0.00124	CcSEcCtD
Perphenazine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000239	0.00124	CcSEcCtD
Perphenazine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000238	0.00123	CcSEcCtD
Perphenazine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.00123	CcSEcCtD
Perphenazine—Nefazodone—ABCB1—peripheral nervous system neoplasm	0.000238	0.0558	CrCbGaD
Perphenazine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000236	0.00122	CcSEcCtD
Perphenazine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000236	0.00122	CcSEcCtD
Perphenazine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000235	0.00122	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.00121	CcSEcCtD
Perphenazine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000233	0.00252	CbGeAlD
Perphenazine—Triflupromazine—ABCB1—peripheral nervous system neoplasm	0.000232	0.0544	CrCbGaD
Perphenazine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.00119	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.00119	CcSEcCtD
Perphenazine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000229	0.00118	CcSEcCtD
Perphenazine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.00118	CcSEcCtD
Perphenazine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.00118	CcSEcCtD
Perphenazine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000227	0.00117	CcSEcCtD
Perphenazine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000225	0.00116	CcSEcCtD
Perphenazine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000224	0.00116	CcSEcCtD
Perphenazine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000224	0.00116	CcSEcCtD
Perphenazine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00114	CcSEcCtD
Perphenazine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000221	0.00114	CcSEcCtD
Perphenazine—Aripiprazole—ABCB1—peripheral nervous system neoplasm	0.000221	0.0519	CrCbGaD
Perphenazine—Trazodone—ABCB1—peripheral nervous system neoplasm	0.00022	0.0516	CrCbGaD
Perphenazine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000219	0.00113	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.00113	CcSEcCtD
Perphenazine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000218	0.00112	CcSEcCtD
Perphenazine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00112	CcSEcCtD
Perphenazine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000216	0.00111	CcSEcCtD
Perphenazine—Pain—Etoposide—peripheral nervous system neoplasm	0.000216	0.00111	CcSEcCtD
Perphenazine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.0011	CcSEcCtD
Perphenazine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000213	0.0011	CcSEcCtD
Perphenazine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000213	0.00229	CbGeAlD
Perphenazine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.00108	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.00107	CcSEcCtD
Perphenazine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000207	0.00107	CcSEcCtD
Perphenazine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000206	0.00106	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.00106	CcSEcCtD
Perphenazine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000203	0.00105	CcSEcCtD
Perphenazine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00105	CcSEcCtD
Perphenazine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000202	0.00105	CcSEcCtD
Perphenazine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.0002	0.00103	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00103	CcSEcCtD
Perphenazine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000199	0.00103	CcSEcCtD
Perphenazine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000198	0.00102	CcSEcCtD
Perphenazine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00101	CcSEcCtD
Perphenazine—Headache—Vincristine—peripheral nervous system neoplasm	0.000195	0.00101	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000988	CcSEcCtD
Perphenazine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000188	0.000973	CcSEcCtD
Perphenazine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000968	CcSEcCtD
Perphenazine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000186	0.000959	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000946	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000937	CcSEcCtD
Perphenazine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000178	0.000921	CcSEcCtD
Perphenazine—Fluphenazine—ABCB1—peripheral nervous system neoplasm	0.000178	0.0418	CrCbGaD
Perphenazine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000894	CcSEcCtD
Perphenazine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000173	0.000891	CcSEcCtD
Perphenazine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000167	0.000861	CcSEcCtD
Perphenazine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00086	CcSEcCtD
Perphenazine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000843	CcSEcCtD
Perphenazine—Clomipramine—ABCB1—peripheral nervous system neoplasm	0.000163	0.0382	CrCbGaD
Perphenazine—Chlorprothixene—ABCB1—peripheral nervous system neoplasm	0.000162	0.0381	CrCbGaD
Perphenazine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000828	CcSEcCtD
Perphenazine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000822	CcSEcCtD
Perphenazine—Headache—Etoposide—peripheral nervous system neoplasm	0.000158	0.000816	CcSEcCtD
Perphenazine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000802	CcSEcCtD
Perphenazine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000801	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000796	CcSEcCtD
Perphenazine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000786	CcSEcCtD
Perphenazine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00078	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00078	CcSEcCtD
Perphenazine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000775	CcSEcCtD
Perphenazine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000772	CcSEcCtD
Perphenazine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000761	CcSEcCtD
Perphenazine—Promethazine—ABCB1—peripheral nervous system neoplasm	0.000144	0.0339	CrCbGaD
Perphenazine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000745	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000742	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000741	CcSEcCtD
Perphenazine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000736	CcSEcCtD
Perphenazine—Trifluoperazine—ABCB1—peripheral nervous system neoplasm	0.000142	0.0334	CrCbGaD
Perphenazine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00073	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000727	CcSEcCtD
Perphenazine—Infection—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000725	CcSEcCtD
Perphenazine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000722	CcSEcCtD
Perphenazine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000718	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000717	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000715	CcSEcCtD
Perphenazine—Quetiapine—ABCB1—peripheral nervous system neoplasm	0.000138	0.0324	CrCbGaD
Perphenazine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000712	CcSEcCtD
Perphenazine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000696	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000689	CcSEcCtD
Perphenazine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000682	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000681	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000675	CcSEcCtD
Perphenazine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000671	CcSEcCtD
Perphenazine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000665	CcSEcCtD
Perphenazine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00066	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000659	CcSEcCtD
Perphenazine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000651	CcSEcCtD
Perphenazine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000649	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000644	CcSEcCtD
Perphenazine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000635	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000631	CcSEcCtD
Perphenazine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000624	CcSEcCtD
Perphenazine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000624	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000611	CcSEcCtD
Perphenazine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000602	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.0006	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000587	CcSEcCtD
Perphenazine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00058	CcSEcCtD
Perphenazine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000578	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000578	CcSEcCtD
Perphenazine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000577	CcSEcCtD
Perphenazine—Chlorpromazine—ABCB1—peripheral nervous system neoplasm	0.000112	0.0262	CrCbGaD
Perphenazine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000538	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000537	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000534	CcSEcCtD
Perphenazine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000516	CcSEcCtD
Perphenazine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.000499	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000498	CcSEcCtD
Perphenazine—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.000483	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.26e-05	0.000478	CcSEcCtD
Perphenazine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	0.000462	CcSEcCtD
Perphenazine—Headache—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000457	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000447	CcSEcCtD
Perphenazine—Headache—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000423	CcSEcCtD
Perphenazine—CALM2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.48e-05	0.000125	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.47e-05	0.000125	CbGpPWpGaD
Perphenazine—CALM2—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.46e-05	0.000124	CbGpPWpGaD
Perphenazine—CALM1—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.46e-05	0.000124	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.46e-05	0.000123	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.46e-05	0.000123	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.45e-05	0.000123	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.45e-05	0.000122	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.45e-05	0.000122	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	1.44e-05	0.000122	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.43e-05	0.000121	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.43e-05	0.00012	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PTPN11—peripheral nervous system neoplasm	1.41e-05	0.000119	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.4e-05	0.000119	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.4e-05	0.000119	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.39e-05	0.000118	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.39e-05	0.000117	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.38e-05	0.000117	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.38e-05	0.000117	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.38e-05	0.000116	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.37e-05	0.000116	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	1.36e-05	0.000115	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PTPN11—peripheral nervous system neoplasm	1.36e-05	0.000115	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PTPN11—peripheral nervous system neoplasm	1.36e-05	0.000115	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	1.36e-05	0.000115	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.35e-05	0.000114	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.35e-05	0.000114	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	1.35e-05	0.000114	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.35e-05	0.000114	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.35e-05	0.000114	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	1.34e-05	0.000113	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.31e-05	0.000111	CbGpPWpGaD
Perphenazine—AOX1—Metabolism—AKT1—peripheral nervous system neoplasm	1.31e-05	0.00011	CbGpPWpGaD
Perphenazine—CALM3—Disease—PTPN11—peripheral nervous system neoplasm	1.3e-05	0.00011	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.29e-05	0.000109	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.29e-05	0.000109	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.28e-05	0.000108	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.27e-05	0.000108	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.27e-05	0.000108	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.27e-05	0.000107	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.27e-05	0.000107	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.27e-05	0.000107	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.26e-05	0.000107	CbGpPWpGaD
Perphenazine—CALM2—Disease—PTPN11—peripheral nervous system neoplasm	1.26e-05	0.000106	CbGpPWpGaD
Perphenazine—CALM1—Disease—PTPN11—peripheral nervous system neoplasm	1.26e-05	0.000106	CbGpPWpGaD
Perphenazine—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000105	CbGpPWpGaD
Perphenazine—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000105	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—TP53—peripheral nervous system neoplasm	1.23e-05	0.000104	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.23e-05	0.000104	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.23e-05	0.000104	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.23e-05	0.000104	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	1.21e-05	0.000103	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—TP53—peripheral nervous system neoplasm	1.19e-05	0.000101	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—TP53—peripheral nervous system neoplasm	1.19e-05	0.000101	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	1.19e-05	0.000101	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—HRAS—peripheral nervous system neoplasm	1.18e-05	9.96e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.18e-05	9.94e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.16e-05	9.84e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.16e-05	9.79e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.14e-05	9.64e-05	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—HRAS—peripheral nervous system neoplasm	1.14e-05	9.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—HRAS—peripheral nervous system neoplasm	1.14e-05	9.64e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.13e-05	9.57e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.13e-05	9.51e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.13e-05	9.51e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.12e-05	9.5e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.12e-05	9.44e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.11e-05	9.42e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.11e-05	9.4e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.11e-05	9.4e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—ERBB2—peripheral nervous system neoplasm	1.11e-05	9.39e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.11e-05	9.36e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.1e-05	9.27e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.1e-05	9.26e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.09e-05	9.25e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.09e-05	9.23e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.09e-05	9.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—ERBB2—peripheral nervous system neoplasm	1.07e-05	9.08e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—ERBB2—peripheral nervous system neoplasm	1.07e-05	9.08e-05	CbGpPWpGaD
Perphenazine—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.07e-05	9.02e-05	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.06e-05	8.97e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.06e-05	8.93e-05	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—AKT1—peripheral nervous system neoplasm	1.04e-05	8.8e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.03e-05	8.7e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.03e-05	8.69e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.03e-05	8.68e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.03e-05	8.68e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—ERBB2—peripheral nervous system neoplasm	1.03e-05	8.67e-05	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	1.02e-05	8.61e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.01e-05	8.57e-05	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—AKT1—peripheral nervous system neoplasm	1.01e-05	8.51e-05	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—AKT1—peripheral nervous system neoplasm	1.01e-05	8.51e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1e-05	8.46e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.96e-06	8.42e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.96e-06	8.42e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—ERBB2—peripheral nervous system neoplasm	9.92e-06	8.38e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—ERBB2—peripheral nervous system neoplasm	9.92e-06	8.38e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	9.86e-06	8.33e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	9.86e-06	8.33e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.69e-06	8.19e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.59e-06	8.1e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.58e-06	8.09e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	9.51e-06	8.04e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	9.46e-06	8e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.44e-06	7.97e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.39e-06	7.93e-05	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—AKT1—peripheral nervous system neoplasm	9.37e-06	7.92e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	9.29e-06	7.85e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.25e-06	7.82e-05	CbGpPWpGaD
Perphenazine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.18e-06	7.75e-05	CbGpPWpGaD
Perphenazine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.13e-06	7.71e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.09e-06	7.68e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.09e-06	7.68e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.08e-06	7.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—AKT1—peripheral nervous system neoplasm	9.07e-06	7.66e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—AKT1—peripheral nervous system neoplasm	9.07e-06	7.66e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.04e-06	7.64e-05	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	9e-06	7.61e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.95e-06	7.56e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.95e-06	7.56e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	8.95e-06	7.56e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.86e-06	7.49e-05	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—AKT1—peripheral nervous system neoplasm	8.82e-06	7.46e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.79e-06	7.43e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.79e-06	7.43e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.79e-06	7.43e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	8.71e-06	7.36e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	8.71e-06	7.36e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.65e-06	7.31e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.63e-06	7.3e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—NRAS—peripheral nervous system neoplasm	8.45e-06	7.14e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.33e-06	7.04e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.29e-06	7e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.29e-06	7e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.25e-06	6.97e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—NRAS—peripheral nervous system neoplasm	8.18e-06	6.91e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—NRAS—peripheral nervous system neoplasm	8.18e-06	6.91e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.15e-06	6.89e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.13e-06	6.87e-05	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.06e-06	6.81e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.98e-06	6.74e-05	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.93e-06	6.7e-05	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.91e-06	6.68e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.87e-06	6.65e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.87e-06	6.65e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.87e-06	6.65e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.85e-06	6.64e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.84e-06	6.62e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—NRAS—peripheral nervous system neoplasm	7.8e-06	6.59e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.62e-06	6.44e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.58e-06	6.41e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—NRAS—peripheral nervous system neoplasm	7.55e-06	6.38e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—NRAS—peripheral nervous system neoplasm	7.55e-06	6.38e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.53e-06	6.36e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.52e-06	6.36e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.42e-06	6.27e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.32e-06	6.18e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	7.3e-06	6.17e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MYC—peripheral nervous system neoplasm	7.27e-06	6.14e-05	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.21e-06	6.09e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.2e-06	6.08e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.18e-06	6.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.18e-06	6.07e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	7.17e-06	6.06e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.15e-06	6.04e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.1e-06	6e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.06e-06	5.97e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MYC—peripheral nervous system neoplasm	7.03e-06	5.94e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MYC—peripheral nervous system neoplasm	7.03e-06	5.94e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.95e-06	5.87e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.95e-06	5.87e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.78e-06	5.73e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.77e-06	5.72e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.69e-06	5.65e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.65e-06	5.62e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.64e-06	5.61e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.58e-06	5.56e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.57e-06	5.55e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.55e-06	5.53e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.55e-06	5.53e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.55e-06	5.53e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.52e-06	5.51e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.48e-06	5.48e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.31e-06	5.33e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.31e-06	5.33e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.23e-06	5.27e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—peripheral nervous system neoplasm	6.18e-06	5.22e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.13e-06	5.18e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.12e-06	5.17e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.99e-06	5.06e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—peripheral nervous system neoplasm	5.98e-06	5.05e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—peripheral nervous system neoplasm	5.98e-06	5.05e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.98e-06	5.05e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.83e-06	4.93e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.8e-06	4.9e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.78e-06	4.88e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.78e-06	4.88e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.72e-06	4.84e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—peripheral nervous system neoplasm	5.71e-06	4.82e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.58e-06	4.71e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.57e-06	4.71e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.55e-06	4.69e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—peripheral nervous system neoplasm	5.52e-06	4.67e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—peripheral nervous system neoplasm	5.52e-06	4.67e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.46e-06	4.62e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—peripheral nervous system neoplasm	5.46e-06	4.61e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.29e-06	4.47e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.29e-06	4.47e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—peripheral nervous system neoplasm	5.28e-06	4.46e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—peripheral nervous system neoplasm	5.28e-06	4.46e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.12e-06	4.32e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.09e-06	4.3e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—peripheral nervous system neoplasm	5.04e-06	4.26e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.04e-06	4.26e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.02e-06	4.25e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.92e-06	4.16e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.92e-06	4.16e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.92e-06	4.16e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.9e-06	4.14e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.89e-06	4.14e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—peripheral nervous system neoplasm	4.88e-06	4.12e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—peripheral nervous system neoplasm	4.88e-06	4.12e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.82e-06	4.07e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.81e-06	4.06e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	4.63e-06	3.91e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.58e-06	3.87e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.38e-06	3.7e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	4.34e-06	3.67e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.32e-06	3.65e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.25e-06	3.59e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.24e-06	3.59e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—peripheral nervous system neoplasm	4.22e-06	3.57e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.18e-06	3.53e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—peripheral nervous system neoplasm	4.08e-06	3.45e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—peripheral nervous system neoplasm	4.08e-06	3.45e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.04e-06	3.42e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.04e-06	3.42e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4e-06	3.38e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.87e-06	3.27e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.87e-06	3.27e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.87e-06	3.27e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	3.67e-06	3.1e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.53e-06	2.98e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.41e-06	2.89e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.41e-06	2.89e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	3.28e-06	2.77e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	3.01e-06	2.55e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	2.99e-06	2.53e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.55e-06	2.16e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.97e-06	1.67e-05	CbGpPWpGaD
